EPL Bio Analytical Services Selects SCIEX QTRAP 6500+ LC-MS System With SelexION Differential Mobility Separation Technology Device

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

SCIEX, (life science analytical technologies), announced today that EPL Bio Analytical Services, (EPL BAS), an agriculture-focused analytical contract laboratory, has selected the SCIEX QTRAP® 6500+ with SelexION®+, enabling their researchers to provide analytical solutions to customers with projects involving difficult matrices that the lab could not previously consider accepting.

EPL’s analytical laboratory provides customized analytical laboratory testing services to the agricultural crop protection, agricultural chemical, agricultural biotechnology, organic, biocontrol, nutritional, food ingredient, and feed industries and they partner with customers from around the world to provide safe and reliable agricultural products to local and global consumers. EPL’s installation of the SCIEX QTRAP 6500+ LC-MS/MS system with multi-component IonDrive™ Technology and a newly designed IonDrive High Energy Detector+, offers them the high sensitivity, reliability and confidence they require to produce data as objective evidence for the efficacy and safety of a wide range agricultural product, including organic products, synthetic chemistry, and plant-incorporated protectants.

The QTRAP 6500+ system delivers enhanced selectivity, without compromising MRM sensitivity, for more flexibility in dealing with complex interferences. The exclusive QTRAP scan function of MS3 (MS/MS/MS), adds an additional level of mass filtering, while the SelexION+ ion mobility provides an orthogonal separation prior to mass separation and offers the lab yet another tool for eliminating isobaric background interferences in complex assays, making quantitation in complex samples easier and less time consuming. The unique scan functions offered by the SCIEX QTRAP system, including enhanced mass scans (EMS), enhanced resolution scans (ER), and enhanced product ion scans (EPI), deliver maximum flexibility and workflow options enabling researchers to embrace new discoveries and more accurate identification that extend beyond quantitation.

“The 6500+ with SelexION allows EPL Bio Analytical Services to have unique product offering and provides a significant competitive advantage that enables their researchers to solve problems other labs cannot,” said Paul Winkler, Food and Beverage Marking Development Manager, Americas at SCIEX. “The acquisition of the QTRAP 6500+ provides EPL Bio Analytical Services with an instrument that has better low mass negative ion performance than their competitors’ laboratories, and with the addition of SelexION, EPL Bio Analytical Services further extends their ability to perform analyses in complex matrices such as environmental and agricultural samples.”

Fred Claussen, VP of Method Development EPL Bio Analytical Services said, “At EPL, the management and staff place a high value on being the industry leader.” Claussen added, “When we find a technology that will provide better data to our customers, we go get it. In the competitive world of contract laboratories, having the best technology, along with the best technical staff allows us to more effectively compete for new business and uphold our strong brand on a global level. We believe that the acquisition of these SCIEX solutions gives our laboratory this important competitive edge.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.